Laursen Van Swieten
Laursen Van Swieten is a venture capital firm based in Shanghai, China, specializing in the commercialization of niche technologies. The firm actively invests in technology companies across the United States, Europe, Israel, and Asia, providing not only capital but also hands-on support to help these companies achieve and maintain leadership within their markets. With extensive experience and access to networks in Europe and Asia, Laursen Van Swieten focuses on facilitating growth and addressing challenges faced by its portfolio companies.
PropTexx is a leader in AI technology for the real estate sector. PropTexx is best described as a global real estate technology company specializing in developing and deploying AI, ML, and Deep Learning solutions. Our core offering is to help improve the quality and representation of online property listings using a number of tech-driven products and processes – all of which have been developed using a range of proprietary algorithms and logic built by a dedicated, professional team over many years.
Private Equity Round in 2021
PropTexx is a leader in AI technology for the real estate sector. PropTexx is best described as a global real estate technology company specializing in developing and deploying AI, ML, and Deep Learning solutions. Our core offering is to help improve the quality and representation of online property listings using a number of tech-driven products and processes – all of which have been developed using a range of proprietary algorithms and logic built by a dedicated, professional team over many years.
Silenseed is a clinical stage biopharmaceutical company that develops proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. The company’ novel drugs, used together with the new delivery system, the LODER™ (LOcal Drug EluteR), have the potential to be one of the most highly effective treatments for solid tumor cancers. Diseases that currently are included in the company’s pipeline are pancreatic cancer, prostate cancer and certain brain cancers.
Private Equity Round in 2019
Soltaro is a developer of solar battery storage solutions designed to support less energy consumption. the company's product uses batteries that are lithium-ion phosphate to offer hybrid batteries or ac retrofit to the existing solar system and helps in storing solar power from existing solar pv, allowing customers to save money on energy bills and store unused electricity.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.